183 related articles for article (PubMed ID: 29603736)
1. Time from breast cancer diagnosis to therapeutic surgery and breast cancer prognosis: A population-based cohort study.
Eriksson L; Bergh J; Humphreys K; Wärnberg F; Törnberg S; Czene K
Int J Cancer; 2018 Sep; 143(5):1093-1104. PubMed ID: 29603736
[TBL] [Abstract][Full Text] [Related]
2. The effect of surgery type on survival and recurrence in very young women with breast cancer.
Quan ML; Paszat LF; Fernandes KA; Sutradhar R; McCready DR; Rakovitch E; Warner E; Wright FC; Hodgson N; Brackstone M; Baxter NN
J Surg Oncol; 2017 Feb; 115(2):122-130. PubMed ID: 28054348
[TBL] [Abstract][Full Text] [Related]
3. Women treated with breast conserving surgery do better than those with mastectomy independent of detection mode, prognostic and predictive tumor characteristics.
Hofvind S; Holen Å; Aas T; Roman M; Sebuødegård S; Akslen LA
Eur J Surg Oncol; 2015 Oct; 41(10):1417-22. PubMed ID: 26253193
[TBL] [Abstract][Full Text] [Related]
4. Analysis of incidence and prognostic factors for ipsilateral breast tumour recurrence and its impact on disease-specific survival of women with node-negative breast cancer: a prospective cohort study.
Nottage MK; Kopciuk KA; Tzontcheva A; Andrulis IL; Bull SB; Blackstein ME
Breast Cancer Res; 2006; 8(4):R44. PubMed ID: 16859523
[TBL] [Abstract][Full Text] [Related]
5. Impact of age, intrinsic subtype and local treatment on long-term local-regional recurrence and breast cancer mortality among low-risk breast cancer patients.
Laurberg T; Alsner J; Tramm T; Jensen V; Lyngholm CD; Christiansen PM; Overgaard J
Acta Oncol; 2017 Jan; 56(1):59-67. PubMed ID: 27846764
[TBL] [Abstract][Full Text] [Related]
6. Clinical benefits of mastectomy on treatment of occult breast carcinoma presenting axillary metastases.
Wang X; Zhao Y; Cao X
Breast J; 2010; 16(1):32-7. PubMed ID: 20465598
[TBL] [Abstract][Full Text] [Related]
7. Effect of Surgery Type on Time to Adjuvant Chemotherapy and Impact of Delay on Breast Cancer Survival: A National Cancer Database Analysis.
Kupstas AR; Hoskin TL; Day CN; Habermann EB; Boughey JC
Ann Surg Oncol; 2019 Oct; 26(10):3240-3249. PubMed ID: 31332635
[TBL] [Abstract][Full Text] [Related]
8. Inadequate treatment of symptomatic breast cancer.
Kingsmore DB; Hole DJ; Gillis CR; George WD
Br J Surg; 2005 Apr; 92(4):422-8. PubMed ID: 15609383
[TBL] [Abstract][Full Text] [Related]
9. Phyllodes tumors of the breast diagnostic and therapeutic dilemmas.
Fajdić J; Gotovac N; Hrgović Z; Kristek J; Horvat V; Kaufmann M
Onkologie; 2007 Mar; 30(3):113-8. PubMed ID: 17341897
[TBL] [Abstract][Full Text] [Related]
10. Age at diagnosis in relation to survival following breast cancer: a cohort study.
Brandt J; Garne JP; Tengrup I; Manjer J
World J Surg Oncol; 2015 Feb; 13():33. PubMed ID: 25889186
[TBL] [Abstract][Full Text] [Related]
11. 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study.
van Maaren MC; de Munck L; de Bock GH; Jobsen JJ; van Dalen T; Linn SC; Poortmans P; Strobbe LJA; Siesling S
Lancet Oncol; 2016 Aug; 17(8):1158-1170. PubMed ID: 27344114
[TBL] [Abstract][Full Text] [Related]
12. [Does primary tumor affect the prognosis in postmastectomy locoregional recurrence in breast carcinoma?].
Willner J; Kiricuta IC; Kölbl O
Strahlenther Onkol; 1995 Jan; 171(1):18-28. PubMed ID: 7839301
[TBL] [Abstract][Full Text] [Related]
13. Better survival after breast-conserving therapy compared to mastectomy when axillary node status is positive in early-stage breast cancer: a registry-based follow-up study of 6387 Norwegian women participating in screening, primarily operated between 1998 and 2009.
Hartmann-Johnsen OJ; Kåresen R; Schlichting E; Nygård JF
World J Surg Oncol; 2017 Jul; 15(1):118. PubMed ID: 28673296
[TBL] [Abstract][Full Text] [Related]
14. Local recurrence risk after previous salvage mastectomy.
Tanabe M; Iwase T; Okumura Y; Yoshida A; Masuda N; Nakatsukasa K; Shien T; Tanaka S; Komoike Y; Taguchi T; Arima N; Nishimura R; Inaji H; Ishitobi M;
Eur J Surg Oncol; 2016 Jul; 42(7):980-5. PubMed ID: 27055945
[TBL] [Abstract][Full Text] [Related]
15. Favorable outcome of secondary axillary dissection in breast cancer patients with axillary nodal relapse.
Shen SC; Liao CH; Lo YF; Tsai HP; Kuo WL; Yu CC; Chao TC; Chen MF; Chang HK; Lin YC; Shen WC; Ueng SH; Lee LY; Hsueh S; Huang YT; Chen SC
Ann Surg Oncol; 2012 Apr; 19(4):1122-8. PubMed ID: 21969085
[TBL] [Abstract][Full Text] [Related]
16. Prognosis following local recurrence after breast conserving treatment in young women with early breast cancer.
van der Sangen MJ; Poortmans PM; Scheepers SW; Lemaire BM; van Berlo CL; Tjan-Heijnen VC; Voogd AC
Eur J Surg Oncol; 2013 Aug; 39(8):892-8. PubMed ID: 23726902
[TBL] [Abstract][Full Text] [Related]
17. [Therapeutic consequences of early detection of locoregional recurrences in breast cancer].
Bahnsen J; Carl UM
Zentralbl Chir; 1993; 118(2):57-62. PubMed ID: 8465614
[TBL] [Abstract][Full Text] [Related]
18. [Breast-conservation treatment for early invasive breast cancer: prognostic factors for survival after salvage treatment of local recurrence].
Fodor J
Magy Onkol; 2007; 51(2):127-31. PubMed ID: 17660868
[TBL] [Abstract][Full Text] [Related]
19. No association between low-dose aspirin use and breast cancer outcomes overall: a Swedish population-based study.
Frisk G; Ekberg S; Lidbrink E; Eloranta S; Sund M; Fredriksson I; Lambe M; Smedby KE
Breast Cancer Res; 2018 Nov; 20(1):142. PubMed ID: 30458873
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of the number of positive lymph nodes in women with T1-2N1 breast cancer treated with mastectomy: should patients with 1, 2, and 3 positive lymph nodes be grouped together?
Dai Kubicky C; Mongoue-Tchokote S
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1200-5. PubMed ID: 23265570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
